Clinical Trials Directory

Trials / Completed

CompletedNCT03106402

Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification

Status
Completed
Phase
Study type
Observational
Enrollment
316 (actual)
Sponsor
Kyungpook National University Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To assess the incidence, risk factors and clinical courses of cystic macular lesions (CMLs) after uncomplicated phacoemulsification and evaluate the efficacy of topical NSAIDs on the prevention of pseudophakic cystic macular lesions

Detailed description

344 Patients undergoing uncomplicated standard phacoemulsification at Kyungpook National University Hospital from 2013 to 2015 were reviewed. CMLs, which is any cystic fluid collections after cataract surgery, were confirmed by preoperative and postoperative optical coherence tomography(OCT) on preoperative, postoperative 1month and 3months examinations. CMLs were classified into two groups: cystic macular edema(CME) and microcystic macular edema(MME).

Conditions

Interventions

TypeNameDescription
DRUGtopical bromfenac sodium hydrate

Timeline

Start date
2013-10-01
Primary completion
2015-06-30
Completion
2015-07-30
First posted
2017-04-10
Last updated
2017-04-10

Source: ClinicalTrials.gov record NCT03106402. Inclusion in this directory is not an endorsement.

Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification (NCT03106402) · Clinical Trials Directory